Haloperidol increases smoking in patients with schizophrenia

Joseph Patrick McEvoy, O. Freudenreich, E. D. Levin, J. E. Rose

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

Ten patients with schizophrenia participated in 120-min free-smoking sessions when actively psychotic and free of antipsychotic medications, and again after the initiation of haloperidol treatment. During these free-smoking sessions they had access to cigarettes ad libitum. Their expired air carbon monoxide (CO) and plasma nicotine and cotinine levels were measured at the end of the 120-min free-smoking sessions. These patients smoked more after starting haloperidol treatment, relative to their baseline rate of smoking when free of antipsychotic medications, as evidenced by significantly higher expired CO and plasma nicotine levels.

Original languageEnglish (US)
Pages (from-to)124-126
Number of pages3
JournalPsychopharmacology
Volume119
Issue number1
DOIs
StatePublished - May 1 1995
Externally publishedYes

Fingerprint

Haloperidol
Schizophrenia
Smoking
Carbon Monoxide
Nicotine
Antipsychotic Agents
Cotinine
Tobacco Products
Air
Therapeutics

Keywords

  • Haloperidol
  • Nicotine
  • Schizophrenia
  • Smoking

ASJC Scopus subject areas

  • Pharmacology

Cite this

Haloperidol increases smoking in patients with schizophrenia. / McEvoy, Joseph Patrick; Freudenreich, O.; Levin, E. D.; Rose, J. E.

In: Psychopharmacology, Vol. 119, No. 1, 01.05.1995, p. 124-126.

Research output: Contribution to journalArticle

McEvoy, JP, Freudenreich, O, Levin, ED & Rose, JE 1995, 'Haloperidol increases smoking in patients with schizophrenia', Psychopharmacology, vol. 119, no. 1, pp. 124-126. https://doi.org/10.1007/BF02246063
McEvoy, Joseph Patrick ; Freudenreich, O. ; Levin, E. D. ; Rose, J. E. / Haloperidol increases smoking in patients with schizophrenia. In: Psychopharmacology. 1995 ; Vol. 119, No. 1. pp. 124-126.
@article{95d33af6fb11430c9f535e602eb48130,
title = "Haloperidol increases smoking in patients with schizophrenia",
abstract = "Ten patients with schizophrenia participated in 120-min free-smoking sessions when actively psychotic and free of antipsychotic medications, and again after the initiation of haloperidol treatment. During these free-smoking sessions they had access to cigarettes ad libitum. Their expired air carbon monoxide (CO) and plasma nicotine and cotinine levels were measured at the end of the 120-min free-smoking sessions. These patients smoked more after starting haloperidol treatment, relative to their baseline rate of smoking when free of antipsychotic medications, as evidenced by significantly higher expired CO and plasma nicotine levels.",
keywords = "Haloperidol, Nicotine, Schizophrenia, Smoking",
author = "McEvoy, {Joseph Patrick} and O. Freudenreich and Levin, {E. D.} and Rose, {J. E.}",
year = "1995",
month = "5",
day = "1",
doi = "10.1007/BF02246063",
language = "English (US)",
volume = "119",
pages = "124--126",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Haloperidol increases smoking in patients with schizophrenia

AU - McEvoy, Joseph Patrick

AU - Freudenreich, O.

AU - Levin, E. D.

AU - Rose, J. E.

PY - 1995/5/1

Y1 - 1995/5/1

N2 - Ten patients with schizophrenia participated in 120-min free-smoking sessions when actively psychotic and free of antipsychotic medications, and again after the initiation of haloperidol treatment. During these free-smoking sessions they had access to cigarettes ad libitum. Their expired air carbon monoxide (CO) and plasma nicotine and cotinine levels were measured at the end of the 120-min free-smoking sessions. These patients smoked more after starting haloperidol treatment, relative to their baseline rate of smoking when free of antipsychotic medications, as evidenced by significantly higher expired CO and plasma nicotine levels.

AB - Ten patients with schizophrenia participated in 120-min free-smoking sessions when actively psychotic and free of antipsychotic medications, and again after the initiation of haloperidol treatment. During these free-smoking sessions they had access to cigarettes ad libitum. Their expired air carbon monoxide (CO) and plasma nicotine and cotinine levels were measured at the end of the 120-min free-smoking sessions. These patients smoked more after starting haloperidol treatment, relative to their baseline rate of smoking when free of antipsychotic medications, as evidenced by significantly higher expired CO and plasma nicotine levels.

KW - Haloperidol

KW - Nicotine

KW - Schizophrenia

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0029009101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029009101&partnerID=8YFLogxK

U2 - 10.1007/BF02246063

DO - 10.1007/BF02246063

M3 - Article

VL - 119

SP - 124

EP - 126

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -